InvestorsHub Logo
Followers 14
Posts 130
Boards Moderated 0
Alias Born 07/23/2020

Re: All-Bidness post# 125667

Thursday, 10/22/2020 9:02:33 PM

Thursday, October 22, 2020 9:02:33 PM

Post# of 233220
Remdesivir has not been proven to significantly reduce mortality in all Severe/Critical patients. If CD12 shows a significant reduction (30%+), it will be filling an unmet need.

Also, Rem is an anti-viral while Leronlimab is an immunomodulator. There is a need for both.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News